Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed Nov 6, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-11-04$5.95/sh−27,172$161,673→ 153,616 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2024-11-04$2.32/sh+27,172$63,039→ 180,788 total(indirect: By Spouse) - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-04$2.32/sh−27,172$63,039→ 27,171 total(indirect: By Spouse)Exercise: $2.32Exp: 2029-01-17→ Common Stock (27,172 underlying)
Holdings
- 77,592(indirect: By Trust)
Common Stock
- 301,946
Common Stock
Footnotes (3)
- [F1]The shares are directly held by the Reporting Person's wife.
- [F2]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
- [F3]The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.